4.4 Article

Syntheses and analytical characterizations of the research chemical 1-[1-(2-fluorophenyl)-2-phenylethyl]pyrrolidine (fluorolintane) and five of its isomers

期刊

DRUG TESTING AND ANALYSIS
卷 11, 期 8, 页码 1144-1161

出版社

WILEY
DOI: 10.1002/dta.2608

关键词

1; 2-diarylethylamines; dissociatives; forensic; new psychoactive substances; NMDA receptor

资金

  1. USciences USURF Program
  2. USciences Spiers Fellowship

向作者/读者索取更多资源

A number of substances based on the 1,2-diarylethylamine template have been investigated for various potential clinical applications whereas others have been encountered as research chemicals sold for non-medical use. Some of these substances have transpired to function as NMDA receptor antagonists that elicit dissociative effects in people who use these substances recreationally. 1-[1-(2-Fluorophenyl)-2-phenylethyl]pyrrolidine (fluorolintane, 2-F-DPPy) has recently appeared as a research chemical, which users report has dissociative effects. One common difficulty encountered by stakeholders confronting the appearance of new psychoactive substances is the presence of positional isomers. In the case of fluorolintane, the presence of the fluorine substituent on either the phenyl and benzyl moieties of the 1,2-diarylethylamine structure results in a total number of six possible racemic isomers, namely 2-F-, 3-F-, and 4-F-DPPy (phenyl ring substituents) and 2-F-, 3-F-, and 4-F-DPPy (benzyl ring substituents). The present study reports the chemical syntheses and comprehensive analytical characterizations of the two sets of three positional isomers. These studies included various low- and high-resolution mass spectrometry platforms, gas- and liquid chromatography (GC and LC), nuclear magnetic resonance (NMR) spectroscopy and GC-condensed phase and attenuated total reflection infrared spectroscopy analyses. The differentiation between each set of three isomers was possible under a variety of experimental conditions including GC chemical ionization triple quadrupole tandem mass spectrometric analysis of the [M + H - HF](+) species. The latter MS method was particularly helpful as it revealed distinct formations of product ions for each of the six investigated substances.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemical Research Methods

Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD)

Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, Alexander Stratford, Anna U. Odland, Adam K. Klein, Geraldine Dowling, Nicola M. Dempster, Jason Wallach, Torsten Passie, Adam L. Halberstadt

DRUG TESTING AND ANALYSIS (2020)

Article Biochemical Research Methods

Synthetic cannabinoid receptor agonists: Analytical profiles and development of QMPSB, QMMSB, QMPCB, 2F-QMPSB, QMiPSB, and SGT-233

Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, Wolfgang Dreiseitel, Geraldine Dowling, Matthew J. Bowden, James P. B. Williamson

Summary: Synthetic cannabinoid receptor agonists (SCRAs) are a diverse group of molecules considered new psychoactive substances (NPS) designed to explore the cannabinoid receptor system. This study extensively characterized a group of SCRAs with sulfamoyl benzoate, sulfamoyl benzamide, and N-benzoylpiperidine based structures, providing useful analytical profiles for researchers and scientists. The research performed by Stargate International set the stage for the development of these compounds, potentially leading to the emergence of new SCRAs with the quinolin-8-yl head group.

DRUG TESTING AND ANALYSIS (2021)

Article Clinical Neurology

Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers

Torsten Passie, Hans-Anton Adams, Frank Logemann, Simon D. Brandt, Birgitt Wiese, Matthias Karst

Summary: Ketamine and its enantiomers, particularly the (S)-enantiomer, have distinct psychological effects which can impact psychopathology and neurocognitive function. While (R)-ketamine appears to have fewer dissociative and psychotomimetic effects at subanesthetic doses, (S)-ketamine may induce more negative psychopathology experiences. The study suggests that the ideal composition of ketamine for treating depression should include (R)-ketamine, as it may offer protective effects against negative psychotomimetic effects compared to (S)-ketamine.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)

Article Biochemical Research Methods

Separating the wheat from the chaff: Observations on the analysis of lysergamides LSD, MIPLA, and LAMPA

Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, Alexander Stratford, Peter Blanckaert, Geraldine Dowling, Matthias Grill, Hannes M. Schwelm, Volker Auwaerter, Stephen J. Chapman

Summary: LSD analogs like MIPLA are being sold on the street market, making it crucial to develop techniques to differentiate them from LSD. This study presents methods using gas chromatography-solid phase infrared spectroscopy and mass spectrometry to distinguish between MIPLA and LAMPA.

DRUG TESTING AND ANALYSIS (2022)

Article Biochemistry & Molecular Biology

In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists QMPSB and QMPCB (SGT-11) Including Isozyme Mapping and Esterase Activity

Matthias J. Richter, Lea Wagmann, Tanja M. Gampfer, Simon D. Brandt, Markus R. Meyer

Summary: The study identified the in vitro phase I/II metabolites of QMPSB and QMPCB and demonstrated the involvement of various monooxygenases and human carboxylesterases in their metabolism. Ester hydrolysis, hydroxylation, and formation of glucuronides and sulfates were observed. Including these metabolites in toxicological screening procedures is recommended based on the results of the in vitro experiments.

METABOLITES (2021)

Article Biochemical Research Methods

Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD)

Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, Benedikt Pulver, Kathleen Morton, Alexander Stratford, Geraldine Dowling, Adam L. Halberstadt

Summary: The research on the novel LSD derivative 1V-LSD suggests that it has hallucinogenic effects similar to LSD but at lower doses. Further studies on its biotransformation and receptor pharmacology are needed to fully elucidate its mechanism of action.

DRUG TESTING AND ANALYSIS (2022)

Editorial Material Biochemical Research Methods

Addressing the challenges in forensic drug chemistry II

Simon D. Brandt, Michael Collins

DRUG TESTING AND ANALYSIS (2022)

Article Biochemistry & Molecular Biology

Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter

Thomas J. F. Angenoorth, Stevan Stankovic, Marco Niello, Marion Holy, Simon D. Brandt, Harald H. Sitte, Julian Maier

Summary: The study highlights the interactions between psychoactive substances and SLC6 monoamine transporters, as well as the potential interactions with human OCTs and hPMAT. The findings suggest the importance of investigating these interactions for regulating monoamine concentrations and drug clearance in the body.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemical Research Methods

Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD

Simon D. Brandt, Pierce Kavanagh, Folker Westphal, Benedikt Pulver, Hannes M. Schwelm, Kyla Whitelock, Alexander Stratford, Volker Auwaerter, Adam L. Halberstadt

Summary: This study characterized a novel lysergamide N,N-diethyl-1-propanoyl-6-(prop-2-en-1-yl)-9,10-didehydroergoline-8 beta-carboxamide (1P-AL-LAD) using various analytical methods. In vitro metabolism studies confirmed that 1P-AL-LAD acted as a prodrug and converted to AL-LAD as the most abundant metabolite. 1P-AL-LAD induced dose-dependent head twitch response (HTR) in mice, similar to other hallucinogenic substances.

DRUG TESTING AND ANALYSIS (2022)

Article Biochemical Research Methods

Analytical profile of the lysergamide 1cP-AL-LAD and detection of impurities

Pierce Kavanagh, Folker Westphal, Benedikt Pulver, Hannes M. Schwelm, Alexander Stratford, Volker Auwaerter, Stephen J. Chapman, Adam L. Halberstadt, Simon D. Brandt

Summary: This study describes the analysis of a novel lysergamides compound, 1cP-AL-LAD, using various chromatographic, mass spectrometric, and spectroscopic methods. The compound was found in both purchased samples and blotters sold online for recreational use. The findings provide valuable information for those interested in the chemistry of lysergamides.

DRUG TESTING AND ANALYSIS (2023)

Article Chemistry, Analytical

In Vitro Metabolic Fate of the Synthetic Cannabinoid Receptor Agonists 2F-QMPSB and SGT-233 Including Isozyme Mapping and Carboxylesterases Activity Testing

Matthias J. Richter, Lea Wagmann, Simon D. Brandt, Markus R. Meyer

Summary: The study identified in vitro metabolites of synthetic cannabinoid receptor agonists 2F-QMPSB and SGT-233, and found suitable targets for toxicological screenings. Different enzymes and human carboxylesterases were involved in their metabolism. Various CYP isoforms played important roles in the metabolism of these compounds.

JOURNAL OF ANALYTICAL TOXICOLOGY (2023)

Article Neurosciences

Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines

Adam L. Halberstadt, Dino Luethi, Marius C. Hoener, Daniel Trachsel, Simon D. Brandt, Matthias E. Liechti

Summary: This study investigated the structure-activity relationships of 4-thio-substituted phenylalkylamines and found that these compounds have psychedelic effects, supporting their classification as psychedelics.

PSYCHOPHARMACOLOGY (2023)

Article Biochemical Research Methods

Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N6-ethylnorlysergic acid N,N-diethylamide (ETH-LAD)

Simon D. Brandt, Pierce V. Kavanagh, Folker Westphal, Benedikt Pulver, Hannes M. Schwelm, Alexander Stratford, Volker Auwaerter, Adam L. Halberstadt

Summary: Preclinical investigations have shown that EIPLA exhibits LSD-like properties and can mimic the effects of known psychedelic drugs, making it important for forensic and clinical research.

DRUG TESTING AND ANALYSIS (2023)

Article Biochemical Research Methods

Acute psychotropic, autonomic, and endocrine effects of 5,6-methylenedioxy-2-aminoindane (MDAI) compared with 3,4-methylenedioxymethamphetamine (MDMA) in human volunteers: A self-administration study

Verena Angerer, Yasmin Schmid, Florian Franz, Heike Gnann, Jan Manuel Speer, Anke Gnann, Stephan Helmecke, Armin Buchwald, Simon D. Brandt, Torsten Passie, Matthias E. Liechti, Volker Auwaerter

Summary: Administration of the new psychoactive substance 5,6-methylenedioxy-2-aminoindane (MDAI) to six volunteers revealed that acute subjective effects were qualitatively comparable with 3,4-methylenedioxymethamphetamine (MDMA) based on psychometric measures. Physiological and endocrine measures were also included. In serum and urine, MDAI could be detected for at least 4 and 6 days.

DRUG TESTING AND ANALYSIS (2023)

Article Chemistry, Medicinal

Investigation of the Structure-Activity Relationships of Psilocybin Analogues

Adam K. Klein, Muhammad Chatha, Lauren J. Laskowski, Emilie Anderson, Simon D. Brandt, Stephen J. Chapman, John D. McCorvy, Adam L. Halberstadt

Summary: This study investigated the pharmacological properties of tryptamine derivatives containing N,N-dialkyl substituents and a 4-hydroxy or 4-acetoxy group, revealing their similar potencies at 5-HT2A and 5-HT2B receptors. The compounds acted as full or partial agonists at 5-HT2 subtypes and induced LSD-like head twitches in mice. O-acetylation reduced the in vitro potency of the compounds but had little effect on their in vivo head twitch response potency, suggesting a prodrug mechanism.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

暂无数据